文章摘要
胡倩,郑丽芳,李洪林,高轩,周子英,王希佳,管倩倩.盐酸倍他司汀联合血塞通治疗后循环缺血性眩晕的效果[J].中国临床保健杂志,2018,21(4):527-530.
盐酸倍他司汀联合血塞通治疗后循环缺血性眩晕的效果
Betahistine hydrochloride and blood plug of combined treatment of posterior circulation ischemic vertigo effect analysis
投稿时间:2018-04-27  
DOI:10.3969/J.issn.1672-6790.2018.04.024
中文关键词: 眩晕,缺血性  倍他司汀  活血祛瘀剂  血液流变学  生活质量
英文关键词: Vertigo,Ischemic  Betahistine  Blood Act Stasis Remov Agents  Hemorheology  Quality of Life〖FL
基金项目:湖北省武汉市卫生计生委医疗卫生科研项目(WX15D04)
作者单位E-mail
胡倩 湖北武汉市普仁医院 神经内科, 5282087@qq.com 
郑丽芳 湖北武汉市普仁医院 神经内科, 575163506@qq.com 
李洪林 武汉钢铁集团公司第二职工医院肿瘤科  
高轩 湖北武汉市普仁医院内分泌科,  
周子英 湖北武汉市普仁医院 神经内科,  
王希佳 湖北武汉市普仁医院 神经内科,  
管倩倩 湖北武汉市普仁医院心内科,武汉 430080  
摘要点击次数: 7041
全文下载次数: 6397
中文摘要:
      目的 观察西药盐酸倍他司汀与中成药血塞通治疗后循环缺血性眩晕的治疗效果。方法 选取92例后循环缺血性眩晕患者,按照随机表法将患者分为观察组(n=46)和对照组(n=46)。对照组给予常规治疗和盐酸倍他司汀治疗,观察组在对照组的基础上联合血塞通治疗。观察患者治疗效果、血液流变学指标、椎基底动脉平均血流速度、生活质量以及不良反应。结果 观察组治疗有效率(91.67%)明显高于对照组(78.33%)(χ2=5.098,P=0.023);观察组在改善患者全血黏度(WBV)、血浆黏度(PV)、血小板黏附率(PAR)方面均优对照组(P<0.05);观察组在改善患者椎基底动脉平均血流速度方面优对照组(P<0.05);观察组在改善患者生活质量方面均优对照组(P<0.05);两组患者均未发现明显不良反应。结论 盐酸倍他司汀与血塞通治疗后循环缺血性眩晕疗效确切,可有效改善血液流变学指标以及椎基底动脉平均血流速度,提高生活质量。
英文摘要:
      Objective To explore the western medicine betahistine hydrochloride and proprietary Chinese medicine blood plug on the clinical curative effect of combination therapy after circulation ischemic vertigo.Methods To choose between August 2015 and August 2015 in qingshan district of wuhan city,hubei province PuRen neurology hospital treated 92 cases of patients with posterior circulation ischemic vertigo.According to the random table method,the patients were randomly divided into observation group(n=46) and the control group(n=46).Control group given conventional treatment and static betahistine injection treatment,the observation group in the control group on the basis of giving blood flux injection.To observe the therapeutic effect of two groups of patients,blood rheology indexes,average vertebral basilar artery blood flow velocity,the quality of life and adverse reaction.Results he efficiency of treatment in the observation group(91.67 %) was significantly higher than that in the control group(78.33 %)(χ2=5.098,P=0.023).The observation group was superior in improving WBV,PV and par(P<0.05).The observation group was superior in improving the mean blood flow velocity of Zhuijidi artery(P<0.05).The observation group was superior to the Control Group in improving the quality of life(P<0.05).No significant adverse effects were found in either group.Conclusion The treatment of cyclic ischemic vertigo with butanastatin hydrochloride and hemostasia is effective in improving the hemorheology index and the average blood flow rate of vertebral basilar artery and improving the quality of life.
查看全文     
关闭
分享按钮